Abaloparatide - Latest Advances

Effect of the COVID-19 Pandemic on Treatment Strategies for Secondary Prevention of Hip Fragility Fractures.

Journal: The Israel Medical Association journal : IMAJ

Published: June 16, 2026

Nf2 orchestrates β-arrestin2-biased PTH1R signaling to couple bone mass with skeletal integrity.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: June 10, 2026

Risk of medication-related osteonecrosis of the jaw during romosozumab treatment.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: April 16, 2026

Osteoclast Precursor Membrane-Coated Nanoparticles Loaded With Abaloparatide Enable Dual Modulation of Osteoclast and Osteoblast Differentiation.

Journal: Applied biochemistry and biotechnology

Published: April 09, 2026

Comparative efficacy and safety of odanacatib, abaloparatide, denosumab, teriparatide, and bisphosphonates for male osteoporosis: a systematic review and network meta-analysis.

Journal: Frontiers in endocrinology

Published: March 23, 2026

The Anabolic-First Strategy in Osteoporosis: A Systematic Review and Meta-Analysis of Fracture Outcomes in Patients at Very High Fracture Risk.

Journal: Medicina (Kaunas, Lithuania)

Published: February 16, 2026

Metabolic bone diseases : what's new in 2025

Journal: Revue medicale suisse

Published: January 22, 2026

Rapid fracture healing of the greater tuberosity fragment after shoulder hemiarthroplasty in a patient with daily abaloparatide injection: A case report.

Journal: Bone reports

Published: December 16, 2025

Mechanisms Underlying the Waning of Osteoanabolic Therapy Effects in Osteoporosis.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Published: December 09, 2025

Clarifying clinically treatment-naive status for osteoporosis patients.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: December 08, 2025

Osteoporosis After Menopause and After Drug Therapy: The Molecular Mechanism of Bone Loss and Its Treatment.

Journal: International journal of molecular sciences

Published: November 24, 2025

Timeliness of Antiresorptive Consolidation After Anabolic Therapy for Primary Fracture Prevention: A U.S. Cohort Study.

Journal: The Journal of clinical endocrinology and metabolism

Published: November 19, 2025